Colorectal Cancer: Surveillance After Curative-Intent Therapy

  • Scott E. RegenbogenEmail author
  • Karin M. Hardiman


There are more than 1.2 million people in the United States in survivorship care after curative resection of colorectal cancer. They face a lifetime of risk for cancer recurrence or metachronous colorectal cancer, yet there is little consensus on optimal approaches to surveillance. For patients willing and able to undergo surgical or medical therapy for recurrence, active, structured surveillance is recommended. This chapter discusses the content, supporting evidence, outcomes, and shortcomings of the major published guidelines for surveillance after curative resection for colorectal cancer.


Survivorship Surveillance Recurrence Metachronous colorectal cancer 

Copyright information

© ASCRS (American Society of Colon and Rectal Surgeons) 2019

Authors and Affiliations

  1. 1.Division of Colorectal SurgeryUniversity of MichiganAnn ArborUSA

Personalised recommendations